The AAN published a new guideline, Practice Guideline: Disease-modifying Therapies for Adults with Multiple Sclerosis, in Neurology® [...]
Recent Posts
- MS Teamworks
- More About MS (2025 Part 1)
- More About MS (2025 Part 2)
- More About MS (2024)
- More ABout MS (2023)
- Dr. Kristen Krysko Wins 2025 Rachel Horne Prize For Women’s Research In Multiple Sclerosis
- Best Practices in Multiple Sclerosis Therapies
- Updates in Cognition and Multiple Sclerosis: Expert Guidance on Management Across on the Continuum of the Disease
- CMSC Press Release – Kathleen Costello, CRNP, MSCN Appointed Interim CEO of the CMSC
- Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

- (201) 487-1050
- 3 University Plz Dr Ste 116, Hackensack, NJ 07601
- info@mscare.org

Upcoming Testing Periods
WINTER 2024 TESTING PERIOD
Application Deadline: December 6th, 2023
First Day of Testing: Saturday, January 6th, 2024
Last Day of Testing: Saturday, January 20th, 2024
SUMMER 2024 TESTING PERIOD
Application Deadline: May 1st, 2024
First Day of Testing: Saturday, June 1st, 2024
Last Day of Testing: Saturday, June 15th, 2024
Resources
For more information:

Professional Testing Corporation http://www.ptcny.com/
- 212-356-0660
- 1350 Broadway, 17th Floor, New York, NY 10018


